Respiratory disease associated with practolol therapy.
Six patients who had surgical treatment for sclerosing peritonitis caused by practolol now have a respiratory disorder characterised by dyspnoea, extensive fibrotic pleural thickening, and lesions in the lung parenchyma. Respiratory disease appears to be a further feature of the practolol syndrome.
D000368:Aged; D004417:Dyspnea / Q000139:chemically induced*; D005260:Female; D006331:Heart Diseases / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D010538:Peritonitis / Q000139:chemically induced; D010995:Pleural Diseases / Q000139:chemically induced*; D011217:Practolol / Q000009:adverse effects* / Q000627:therapeutic use; D001261:Pulmonary Atelectasis / Q000139:chemically induced*; D012598:Sclerosis; D013577:Syndrome
D011217:Practolol